A Merck partner is sucked into the financial quagmire as key lender calls in a note
Another biotech standing on shaky financial legs has fallen victim to the bears.
Merck partner 4D Pharma has reported that a key lender, Oxford Finance …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
